Ruxolitinib phosphate is a phosphate salt of ruxolitinib, formed by reacting ruxolitinib with one equivalent of phosphoric acid. It functions as a non-specific protein-tyrosine kinase inhibitor and is used as an antineoplastic agent in pharmaceutical manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1092939-17-7
Ruxolitinib hydrochloride
active pharmaceutical ingredient
Ruksolitinib
active pharmaceutical ingredient
B-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(bR)-1H-pyrazole-1-propanenitrile,(2Z)-2-butenedioate)
Research compound
Rosuvastatin diastereomers
pharmaceutical impurity reference standard
Methadone hydrochloride
active pharmaceutical ingredient
4-(2-(Benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol
adrenaline impurity reference standard
Loperamide oxide
anti-diarrheal active pharmaceutical ingredient
Deuruxolitinib phosphate
active pharmaceutical ingredient
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid
JFMWPOCYMYGEDM-XFULWGLBSA-N
C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O